Equity Bargain Strains

The hardest negotiation shifts from the declaration itself to who pays and how vaccines, diagnostics, and pathogen samples are shared. Developing countries push for guaranteed access and manufacturing capacity, while pharmaceutical producers and high-income governments resist open-ended intellectual-property commitments.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.